Marissa Fayer in Conversation with Amanda Ducach
Join Marissa Fayer to discuss her latest release, Undervalued to Unavoidable, which encourages decision-makers to treat women's healthcare as investment-worthy infrastructure, rather than simply a cause to support.
The event includes a discussion moderated by Amanda Ducach, Founder and CEO of EmaEQ, a women’s health AI company, followed by audience Q&A and book signing.
Tickets: $20 (admission w/ book), $12.50 (general admission)
Note: Tickets are non-refundable but can be transferred, if you are unable to attend.
About Undervalued to Unavoidable:
The investment case and playbook for treating women's health as infrastructure.
The global economy loses nearly $1 trillion annually because women's health has been treated as a moral issue to fund after more urgent priorities, a niche market with limited upside, a cause to support rather than infrastructure to invest in. That framing error shapes everything downstream: research agendas, product pipelines, capital allocation, workforce policy, and the performance of organizations that have never thought to connect their decisions to it.
Every major book on women's health has diagnosed this problem. Undervalued to Unavoidable does something none of them do. It gives decision-makers the tools to act on it.
The book moves through three parts. The first establishes the economic foundation—the structural reasons the gap persists and the data that makes this a business argument, not a values one. The second maps what organizations making real progress have in common and what failure patterns look like across sectors and geographies. The third is operational: what to do, by role and by leverage point, because the CHRO's decisions are different from the investor's, which are different from the operator's.
About Marissa Fayer:
Marissa Fayer is a four-time venture-backed medtech CEO and global health operator with twenty-five years of experience across four continents inside the systems this book is about. She’s CEO of DeepLook Medical, an FDA-cleared AI diagnostics company focused on breast imaging for women with dense tissue, World Economy Forum Technology Pioneer, and founder and CEO of HERhealthEQ, a nonprofit operating across twelve countries that has reached more than 135,000 women. She writes, speaks, and advises at the intersection of capital, impact, operations, and care delivery. Learn more at marissafayer.com.
About Amanda Ducach:
Amanda Ducach is the founder and CEO of EmaEQ, where she created the first AI platform built specifically for women's health in 2019. EmaEQ is built on millions of real women's health conversations, proprietary science and safety frameworks, and collaborations with leading health organizations, delivering clinically accurate, ethically grounded AI at scale. EmaEQ is a a Reckitt Catalyst (alongside Serena Williams) company, and was named AI Innovation of the Year by Femtech World 2025. Amanda also co-founded the first Women's Health AI Consortium globally.